Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jinye Mi

Showing results (1-10 of 3) with videos related to

Pageof 1
Sort By:
Lung Cancer (Amsterdam, Netherlands)|March 26, 2020
A novel ROS1 G2032 K missense mutation mediates lorlatinib resistance in a patient with ROS1-rearranged lung adenocarcinoma but responds to nab-paclitaxel plus pembrolizumabYuling Zhou, Wenjuan Jiang, Liang Zeng, et al.
BMC Cancer|May 15, 2023
Clinical activity of pembrolizumab with or without chemotherapy in advanced pulmonary large-cell and large-cell neuroendocrine carcinomas: a multicenter retrospective cohort studyLianxi Song, Fei Zhou, Tian Xu, et al.
Neoplasia (New York, N.Y.)|June 14, 2021
mTORC2 regulates ribonucleotide reductase to promote DNA replication and gemcitabine resistance in non-small cell lung cancerLing Tian, Congcong Chen, Yanguan Guo, et al.
Pageof 1

Showing results (1-10 of 3) with videos related to

Sort By:
Pageof 1
Lung Cancer (Amsterdam, Netherlands)|March 26, 2020
A novel ROS1 G2032 K missense mutation mediates lorlatinib resistance in a patient with ROS1-rearranged lung adenocarcinoma but responds to nab-paclitaxel plus pembrolizumabYuling Zhou, Wenjuan Jiang, Liang Zeng, et al.
BMC Cancer|May 15, 2023
Clinical activity of pembrolizumab with or without chemotherapy in advanced pulmonary large-cell and large-cell neuroendocrine carcinomas: a multicenter retrospective cohort studyLianxi Song, Fei Zhou, Tian Xu, et al.
Neoplasia (New York, N.Y.)|June 14, 2021
mTORC2 regulates ribonucleotide reductase to promote DNA replication and gemcitabine resistance in non-small cell lung cancerLing Tian, Congcong Chen, Yanguan Guo, et al.
Pageof 1